Latest Monoclonal antibodies Stories
MONROVIA, Calif., July 24, 2014 /PRNewswire/ -- Xencor, Inc.
Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Nearly half a million dollars given to early-career physicians to study psoriatic disease PORTLAND, Ore., July 17, 2014 /PRNewswire-USNewswire/ -- Twelve residents and medical students each
MONROVIA, Calif., July 15, 2014 /PRNewswire/ -- Xencor, Inc.
The increasing number of research activities, coupled with the introduction of advanced technologies in chromatography instruments and consumables, will drive the growth of chromatography systems
Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit.
Scientists at the inter-university Messerli Research Institute of the Vetmeduni Vienna, the Medical University of Vienna, and the University of Vienna have developed, for the first time, antibodies to treat cancer in dogs.
High demand for chromatography reagents in the pharmaceutical industry and innovation in chromatography reagents market will propel the global size exclusion chromatography reagents market.
- A poem in which the author retracts something said in an earlier poem.
More Images (1 images) »